CRISPR/Cas9 genome editing to treat sickle cell disease
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.
Autor principal: | Ullah, Mohammad |
---|---|
Altres autors: | Islam, Farzana |
Format: | Thesis |
Idioma: | English |
Publicat: |
Brac University
2023
|
Matèries: | |
Accés en línia: | http://hdl.handle.net/10361/19355 |
Ítems similars
-
CRISPR/Cas9 system: A versatile gene editing tool in disease prevention and treatment
per: Maria, Amatul
Publicat: (2020) -
Prevalence and application of an evolving genome editing tool “CRISPR/Cas System” in cancer research and treatment
per: Shaikat, Mahdi Mubin
Publicat: (2023) -
A review on CRISPR-Cas system based applications in Oncology
per: Sadia, Mir
Publicat: (2022) -
A review on CRISPR Technology as an Antiviral Tool
per: Srishti, Sanjida Ahmed
Publicat: (2023) -
CRISPR: a revolutionary tool for modeling and treating cancer and Duchenne muscular dystrophy
per: Eva, Israt Ara Jannat
Publicat: (2023)